O'Driscoll Kathryn 4
4 · Zymeworks Inc. · Filed Mar 17, 2021
Insider Transaction Report
Form 4
Zymeworks Inc.ZYME
O'Driscoll Kathryn
Chief People Officer
Transactions
- Sale
Common Shares
2021-03-15$34.72/sh−786$27,290→ 5,003 total - Exercise/Conversion
Common Shares
2021-03-15$34.24/sh+837$28,659→ 5,840 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-03-15−837→ 94,160 totalExercise: $34.24Exp: 2029-11-07→ Common Shares (837 underlying)
Footnotes (1)
- [F1]Stock options vest as follows: (i) 25% of underlying shares on first anniversary of grant date of November 8, 2019, and (ii) remainder of underlying shares in 36 equal monthly installments on last day of month following first anniversary of grant date.